Germany covid-19 president testing Germany

BioNTech inks Covid-19 vaccine deals with Pfizer and Fosun

Reading now: 625
www.pharmaceutical-technology.com

Visit our Covid-19 microsite for the latest coronavirus news, analysis and updates German biotechnology firm BioNTech has partnered with Pfizer to jointly develop and distribute a potential mRNA-based Covid-19 vaccine.

The parties have implemented a material transfer and collaboration agreement to begin working. This agreement expands the research and development (R&D) alliance signed by the companies in 2018 to develop mRNA-based vaccines against influenza.

With the latest collaboration, the companies aim to speed-up the development of BioNTech’s BNT162 as a potential Covid-19 vaccine.

The candidate should advance into clinical testing next month. Pfizer development & medical worldwide research president Mikael Dolsten said: “We

Read more on pharmaceutical-technology.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA